Literature DB >> 9032124

Th1/Th2 cell distribution in pulmonary sarcoidosis.

I Bäumer1, G Zissel, M Schlaak, J Müller-Quernheim.   

Abstract

Cytokines released by T lymphocytes activated in the course of sarcoidosis, e.g., interleukin-2 (IL-2) and interferon-gamma (IFN-gamma), indicate the presence of Th1 cells leading to the question of Th1/Th0/Th2 balance in sarcoidosis. The aim of this study was to evaluate Th-like cytokine patterns in different compartments of the body, i.e., peripheral blood, pulmonary parenchyma, and bronchoalveolar lavage (BAL), of patients with pulmonary sarcoidosis by comparing cytokine gene expression of 167 T-cell clones derived from the above-mentioned compartments. Seventy-nine blood, 49 transbronchial biopsy, and 39 BAL clones were analyzed using polymerase chain reaction to identify the respective gene transcripts. The majority of CD4+ and CD8+ blood cells exhibited intermediate cytokine profiles (63.3%) without shifts to either side of the spectrum (6.3% Th1, 5.1% Th2). Lung parenchyma cells shifted to the Th1 side of the spectrum: 26.5% of the cells were of Th1 or of intermediate type (between Th1 and Th0), whereas only 8.1% of the cells were of Th2 or of intermediate type (between Th0 and Th2). CD8+ parenchyma cells were evenly distributed. From BAL only CD4+ clones could be generated with shifts to both ends of the spectrum. Thus, our data provide evidence that in sarcoidosis, at the site of granuloma formation, an accumulation of Th1 cells as well as of intermediate (between Th1 and Th0) cell types occurs, whereas in the alveolar lumen, high numbers of Th1 and Th2 cells with a simultaneous decrease of Th0 cells can be observed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9032124     DOI: 10.1165/ajrcmb.16.2.9032124

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  15 in total

1.  Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis.

Authors:  M Möllers; S P Aries; D Drömann; B Mascher; J Braun; K Dalhoff
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

2.  Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.

Authors:  A Prasse; C G Georges; H Biller; H Hamm; H Matthys; W Luttmann; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

3.  M2 polarized macrophages and giant cells contribute to myofibrosis in neuromuscular sarcoidosis.

Authors:  Stefan Prokop; Frank L Heppner; Hans H Goebel; Werner Stenzel
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Interferon-induced sarcoidosis.

Authors:  Cláudia Cardoso; Ricardo Freire; Ana Alves; Ana Oliveira
Journal:  BMJ Case Rep       Date:  2011-04-19

5.  Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease.

Authors:  Karen C Patterson; Beverly S Franek; Joachim Müller-Quernheim; Anne I Sperling; Nadera J Sweiss; Timothy B Niewold
Journal:  Cytokine       Date:  2013-02-04       Impact factor: 3.861

6.  Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis.

Authors:  Vyacheslav Palchevskiy; Nastran Hashemi; Stephen S Weigt; Ying Ying Xue; Ariss Derhovanessian; Michael P Keane; Robert M Strieter; Michael C Fishbein; Jane C Deng; Joseph P Lynch; Robert Elashoff; John A Belperio
Journal:  Fibrogenesis Tissue Repair       Date:  2011-04-04

7.  The immune paradox of sarcoidosis and regulatory T cells.

Authors:  Makoto Miyara; Zahir Amoura; Christophe Parizot; Cécile Badoual; Karim Dorgham; Salim Trad; Marianne Kambouchner; Dominique Valeyre; Catherine Chapelon-Abric; Patrice Debré; Jean-Charles Piette; Guy Gorochov
Journal:  J Exp Med       Date:  2006-01-23       Impact factor: 14.307

8.  Tumor necrosis factor-alpha inhibitor treatment for sarcoidosis.

Authors:  José Luis Callejas-Rubio; Lourdes López-Pérez; Norberto Ortego-Centeno
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

9.  Comparative analysis of circulating dendritic cell subsets in patients with atopic diseases and sarcoidosis.

Authors:  Yumeko Hayashi; Yoshiki Ishii; Mitsumi Hata-Suzuki; Ryo Arai; Kazuyuki Chibana; Akihiro Takemasa; Takeshi Fukuda
Journal:  Respir Res       Date:  2013-03-04

10.  Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels.

Authors:  Anne Saussine; Abdellatif Tazi; Séverine Feuillet; Michel Rybojad; Caroline Juillard; Anne Bergeron; Valérie Dessirier; Fatiha Bouhidel; Anne Janin; Armand Bensussan; Martine Bagot; Jean-David Bouaziz
Journal:  PLoS One       Date:  2012-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.